Clinical trial Recruiting at 1 site Observational Ages 18 and up

Predicting afterload mismatch after transcatheter mitral edge-to-edge repair

Official title: Afterload Mismatch Predictive modLE for Transcatheter Edge-to-Edge Repair (AMPLE-TEER Study)

Run by Sun Yat-sen University · NCT07019935 · Data updated 2026-11-12

It will test a model to predict which adults having transcatheter mitral valve edge-to-edge repair will develop afterload mismatch after the procedure.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorSun Yat-sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedOctober 1, 2021
Main results expectedOctober 1, 2030
Study endsOctober 1, 2030
Registry record updatedJune 13, 2025
Trial IDNCT07019935 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 undergoing TEER at the enrolling hospital who can provide written informed consent are the intended participants.

Probably not a fit

Patients not undergoing TEER, those unable to give written consent, or those with incomplete follow-up/data are unlikely to benefit from this predictive approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

AMPLE-TEER is a prospective observational effort to develop a predictive model for afterload mismatch in patients undergoing transcatheter mitral valve edge-to-edge repair (TEER). The study will enroll adults treated with TEER at The First Affiliated Hospital of Sun Yat-sen University and collect clinical, echocardiographic, and hemodynamic data before, during, and after the procedure. Investigators will analyze these variables to identify factors associated with post-procedural afterload mismatch and adverse ventricular remodeling. The aim is to enable earlier intervention and better postoperative management for high-risk patients.

Why it matters

Potential benefit: If successful, the predictive model could help clinicians identify patients at high risk for afterload mismatch early so they can adjust care to reduce ventricular remodeling, hospitalizations, and mortality.

How similar studies have gone: Prior observational reports have identified risk factors for afterload mismatch after TEER, but comprehensive prospective predictive models are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing transcatheter mitral valve edge-to-edge repair (TEER) during hospitalization.
* Aged over 18 yrs.

Exclusion Criteria:

* Patients unable to provide written consent.

Where it's running

  • The First Affiliated Hospital of Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.